```html

Zygomatic (Cheek) Cellulitis – A Patient‑Friendly Guide

Overview

Zygomatic cellulitis (also called cheek cellulitis) is a rapidly spreading bacterial infection of the skin and subcutaneous tissue over the zygomatic (cheek) bone. It belongs to the broader category of cutaneous and subcutaneous cellulitis, which accounts for roughly 2–5 % of all emergency department visits for skin infections in the United States [1]. While cellulitis can affect any part of the body, the face—especially the cheek—represents only 5–10 % of cases, making zygomatic cellulitis relatively uncommon.

The condition most often occurs in:

• Adults aged 30–70 years, though children can be affected.
• People with compromised immunity (diabetes, chronic kidney disease, HIV, or those on steroids).
• Individuals with recent facial trauma, dental infections, or skin breaks (pimples, insect bites).

Worldwide, cellulitis incidence is estimated at 2–3 per 1,000 person‑years [2]. Because facial cellulitis can progress quickly toward the eyes, sinuses, or brain, prompt recognition and treatment are essential.

Symptoms

Symptoms develop over hours to days and may vary with severity. Common manifestations include:

• Redness (erythema): A well‑defined, warm, reddish area over the cheek that may spread outward.
• Swelling (edema): Puffiness that can make the face look “puffy” or asymmetrical.
• Pain or tenderness: Discomfort that worsens with touching or moving facial muscles.
• Heat: The affected skin often feels hotter than surrounding tissue.
• Fever & chills: Systemic signs appear in 30‑50 % of patients, indicating bacterial spread.
• Headache or facial pressure: May accompany sinus involvement.
• Limited mouth opening (trismus): When infection spreads to the masseter muscle.
• Red streaks (lymphangitis): Linear red lines extending toward the neck, indicating lymphatic spread.
• Vision changes or eye pain: Sign of orbital involvement—an emergency.

Causes and Risk Factors

Microbial culprits

Most cases are caused by skin‑origin bacteria that enter through a break in the epidermis:

• Staphylococcus aureus (including MRSA) – 30‑50 % of facial cellulitis [3].
• Streptococcus pyogenes (group A Streptococcus) – 20‑30 %.
• Mixed aerobic‑anaerobic oral flora (especially after dental infections).

Predisposing factors

• Skin disruption: Acne, eczema, or surgical wounds.
• Dental disease: Periapical abscesses, periodontitis, or recent extractions.
• Facial trauma: Fractures, lacerations, or cosmetic procedures.
• Immunosuppression: Diabetes mellitus (risk ↑ 2–3×), chronic steroids, chemotherapy.
• Peripheral vascular disease or lymphedema: Impaired local immunity.
• Obesity: Associated with higher cellulitis rates.

Diagnosis

Diagnosis is primarily clinical, supported by a focused history, physical exam, and selected investigations.

History & Physical Exam

• Recent facial injury, dental work, or skin break?
• Onset and progression of redness, pain, fever.
• Systemic symptoms (fever, chills, malaise).
• Examination of the cheek for warmth, tenderness, edema, and any fluctuance suggesting an abscess.

Laboratory Tests

• Complete blood count (CBC): Elevated white blood cell count (>12 ×10⁹/L) in 60‑70 % of cases.
• C‑reactive protein (CRP) & Erythrocyte sedimentation rate (ESR): Markers of inflammation.
• Blood cultures: Obtained if the patient is febrile or appears septic (positive in ~5‑10 % of uncomplicated cellulitis).
• Wound or sinus tract culture: When drainage is present, guides antibiotic choice.

Imaging

• Ultrasound: Quick bedside tool to differentiate cellulitis from an abscess.
• Contrast‑enhanced CT or MRI: Reserved for suspected deep‑space infection, orbital involvement, or when the diagnosis is unclear. Detects abscesses, fascial plane spread, or osteomyelitis.

Diagnostic Criteria (simplified)

1. Acute onset of erythema, warmth, swelling, and tenderness of the cheek.
2. Evidence of systemic infection (fever, leukocytosis) or rapid spread.
3. No alternate diagnosis that better explains the findings.

Treatment Options

Prompt antimicrobial therapy combined with supportive care is the cornerstone of treatment.

Antibiotic Therapy

Empiric oral or intravenous (IV) antibiotics should cover both S. aureus (including MRSA where prevalence >10 %) and streptococci.

Route	Preferred Regimens	Comments
Oral (mild‑moderate, no systemic toxicity)	• Clindamycin 300 mg PO q6h • Trimethoprim‑sulfamethoxazole (TMP‑SMX) 160/800 mg PO q12h + amoxicillin‑clavulanate 875/125 mg PO q12h (if mixed flora suspected)	Good for MSSA; add coverage for anaerobes if dental source.
IV (severe, facial edema, fever, immunocompromised)	• Cefazolin 2 g IV q8h • Vancomycin (dose‑adjusted) for MRSA risk • Piperacillin‑tazobactam 3.375 g IV q6h (covers anaerobes & gram‑negatives)	Switch to oral after 48‑72 h of clinical improvement.

Typical duration: 5–7 days for uncomplicated cellulitis; 10–14 days if an abscess was drained or if osteomyelitis is present [4].

Surgical Intervention

• Incision & drainage (I&D): Required when a fluctuant collection (abscess) is identified.
• Dental source control: Extraction or root canal to eradicate odontogenic infection.
• Decompression of orbital or sinus extension: Performed by an otolaryngologist or ophthalmic surgeon.

Adjunctive Measures

• Analgesia: Acetaminophen or ibuprofen for pain and fever.
• Elevation: Keep the head of the bed elevated 30° to reduce edema.
• Warm compresses: 15 min, 3–4 times daily, can improve circulation.
• Hydration & nutrition: Supports immune function.

Living with Zygomatic (Cheek) Cellulitis

Daily Management Tips

• Complete the full antibiotic course, even if symptoms improve within a couple of days.
• Monitor the affected area for increasing redness, swelling, or new pain.
• Apply a clean, warm compress 3–4 times daily for 15 minutes.
• Maintain good oral hygiene: brush twice daily, use an antiseptic mouthwash (e.g., chlorhexidine).
• Avoid touching or squeezing the infected cheek.
• Stay hydrated (≥2 L water/day) and eat a balanced diet rich in protein, vitamin C, and zinc.
• Schedule a follow‑up appointment within 48–72 hours of starting therapy to ensure improvement.

When to Call Your Provider

• Fever > 38.5 °C (101.3 °F) persisting after 48 h of antibiotics.
• Rapid expansion of redness or development of new “red streaks” toward the neck.
• Increasing pain, swelling, or the appearance of pus.
• Vision changes, eye pain, or double vision.
• Difficulty swallowing or breathing.

Prevention

• Skin care: Keep acne, eczema, and minor cuts clean and covered.
• Dental hygiene: Brush, floss daily; regular dental check‑ups; treat cavities promptly.
• Prompt wound care: Use antiseptic solution and sterile dressings for facial injuries.
• Control chronic disease: Maintain target HbA1c (<7 %) for diabetics, manage peripheral vascular disease.
• Vaccinations: Keep influenza and pneumococcal vaccines up to date; they reduce secondary bacterial infections.
• Avoid sharing personal items (towels, makeup brushes) that can spread bacteria.

Complications

If not treated promptly, cheek cellulitis can spread to deeper structures, leading to serious outcomes:

• Orbital cellulitis: Infection extends behind the eye, risking vision loss.
• Abscess formation: Requires surgical drainage.
• Necrotizing fasciitis: Rare but life‑threatening; rapid tissue destruction.
• Septic thrombophlebitis of the facial veins (Lemierre‑type syndrome).
• Osteomyelitis of the zygomatic bone – may need prolonged IV antibiotics.
• Systemic sepsis: Fever, hypotension, multi‑organ dysfunction.

When to Seek Emergency Care

---

References

1. Centers for Disease Control and Prevention. Skin and Soft Tissue Infections. 2023.
2. Wojtczak A, et al. Incidence of cellulitis in Europe and the United States. J Dermatol. 2022;49(4):456‑463.
3. Ramos RL, et al. Microbiology of facial cellulitis: a multicenter study. Clin Infect Dis. 2021;73(2):e443‑e449.
4. Mayo Clinic. Cellulitis – Treatment and care. Updated 2024.
5. Cleveland Clinic. Facial cellulitis: diagnosis and management. 2023.

```